reference/4623778

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4623778

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	3023
issn	0021-9738 1558-8238
issueIdentifier	7
pageRange	3008-3023
publicationName	The Journal of clinical investigation
startingPage	3008
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_274de0cd095daad44a563971b32f4582 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c193aa76315df31710c034152ba391c2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a6b8cc25d15a8291bea0903220cc030f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e30572d197999e04bc0fc8d144f96e86
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_08e7977a942883128207c3facc82b2b8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0249f8adf16d8c1c5e33678b9bb44be0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1c6f55594a52624047996ff1b6379b5e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4f5d792705c3afa308fb5c7db19d6a79 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ad3425583a4904ec10b126f7e1076347 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_63f185062cd2bb444b9a95769cfc2e7a
bibliographicCitation	Rodriguez-Muela N, Parkhitko A, Grass T, Gibbs RM, Norabuena EM, Perrimon N, Singh R, Rubin LL. Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes. J Clin Invest. 2018 Jul 02;128(7):3008–23. PMID: 29672276; PMCID: PMC6025996.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_254226042c1e959175a3e838b2f0cdd4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fc9c478fff16bee85cac975e45bde44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be0fee46a4723af243c05906b305cb03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9852-8329 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1065-1870 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbd81e79cb2a1408409c6b3ba2b50fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8497e40028e50a50feaa96759d977cdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7800c9f96e27b6c54563e65a233d8077 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f680d69ac8cac92aeba0e2d23100bff2
date	2018-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6025996 https://pubmed.ncbi.nlm.nih.gov/29672276 https://doi.org/10.1172/jci95231
isPartOf	https://portal.issn.org/resource/ISSN/0021-9738 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632 https://portal.issn.org/resource/ISSN/1558-8238
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes
discusses	http://id.nlm.nih.gov/mesh/M0484290 http://id.nlm.nih.gov/mesh/M0406100 http://id.nlm.nih.gov/mesh/M0518285 http://id.nlm.nih.gov/mesh/M0360401 http://id.nlm.nih.gov/mesh/M0469193 http://id.nlm.nih.gov/mesh/M0265716 http://id.nlm.nih.gov/mesh/M000614776 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0261697
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D055532Q000378 http://id.nlm.nih.gov/mesh/D009134Q000188 http://id.nlm.nih.gov/mesh/D009134Q000378 http://id.nlm.nih.gov/mesh/D000071456Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018345 http://id.nlm.nih.gov/mesh/D055532Q000172 http://id.nlm.nih.gov/mesh/D000071456Q000378 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D009134Q000473 http://id.nlm.nih.gov/mesh/D059748 http://id.nlm.nih.gov/mesh/D010641 http://id.nlm.nih.gov/mesh/D055533Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D057809 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D055533Q000378 http://id.nlm.nih.gov/mesh/D034741Q000235 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D055785 http://id.nlm.nih.gov/mesh/D058570Q000378 http://id.nlm.nih.gov/mesh/D002478 http://id.nlm.nih.gov/mesh/D009046Q000378 http://id.nlm.nih.gov/mesh/D000071456Q000235 http://id.nlm.nih.gov/mesh/D055533Q000037 http://id.nlm.nih.gov/mesh/D001343 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D055532Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3767f5f1bf41806255b8625c2410f512 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_50343c46c40c492ee979f41374f4f07e http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_85f60e669da71a364695a93870624c58 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fb33c402d7e7404a8d061905b558e798 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_27c31a5f0faaecba51c974bcda96f303 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_79f7e890beec570e2170ef7ecbdd085f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3971961025c95bc272d7a66831f7e7b1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a93515c9acafc7027e1ee765d08941c4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_edd1339cd98936bf0263c38f36deae54 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8543

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6606 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8878 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18412 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20595

Total number of triples: 95.